Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Shareholders Approve Actavis-Warner Chilcott Deal

By Pharmaceutical Processing | September 10, 2013

Drugmakers Actavis and Warner Chilcott said Tuesday that their shareholders have approved the combination of the two companies.

Actavis, of Parsippany, N.J., reached a deal to buy Ireland-based Warner Chilcott in May for $8.5 billion. The acquisition will expand Actavis’ women’s health and urology business and give it a range of dermatology and gastroenterology products.

The new Actavis will be the third-largest specialty pharmaceutical company in the U.S. market.

Regulators and the Irish High Court still have to approve the deal. The companies expect to complete the transaction early in the fourth quarter.

Actavis was formed in October through a $5.6 billion tie-up between Watson Pharmaceuticals and Actavis Group. After Watson bought Actavis, it changed its name to Actavis Inc. The company says it will have about $11 billion in annual revenue after buying Warner Chilcott. It will incorporate in Ireland as part of the deal, which could reduce its tax liabilities.

Shares of Actavis were unchanged at $135.90 in morning trading and Warner Chilcott PLC shares rose 3 cents to $21.65.

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE